世界卫生组织发布报告评估了2022-2030年全球健康部门战略的进展，在HIV、病毒性肝炎和性传播感染防控中取得重要成果。[1]截至2025年底，约3200万HIV患者正在接受治疗，[1]自2010年以来新增HIV感染下降42%，艾滋病相关死亡下降57%。[1]同时，自2015年以来乙肝感染年增长率下降32%，丙肝相关死亡下降12%。[1]
然而，防控工作仍面临严峻挑战。仍有900万人无法获得HIV救命治疗。[1]在病毒性肝炎方面，2024年约130万人因此丧生，[1]且自2015年以来乙肝相关死亡反而增加17%。[1]2025年国际捐助资金减少导致多国预防项目中断，暴露前预防用药（PrEP）获取受阻。[1]
面对这些挑战，WHO总干事Tedros Adhanom Ghebreyesus强调："我们必须建立集成化、有韧性的卫生系统，服务最需要帮助的人群。"[1]WHO发布了首份整合HIV服务交付指南和HIV监测指南，[1]同时推进创新治疗方案的推广——Lenacapavir已在10个国家推出，计划在另外14个国家推广。[1]WHO强调需要建立集成化、有韧性的卫生系统，优先推进社区参与和数字健康解决方案。[1]
The World Health Organization has released an assessment of global progress in combating HIV, viral hepatitis, and sexually transmitted infections under its 2022-2030 health sector strategy [1]. The report, presented at the 26th International AIDS Conference (AIDS 2026), reveals significant achievements alongside persistent challenges that threaten continued progress.
Treatment coverage has expanded substantially, with approximately 32 million people living with HIV receiving antiretroviral therapy by the end of 2025 [1]. Since 2010, new HIV infections have declined by 42 percent and AIDS-related deaths have dropped by 57 percent [1]. However, progress remains incomplete—approximately 9 million people still lack access to lifesaving HIV treatment [1]. The hepatitis response has also shown improvement, with a 32 percent decline in annual hepatitis B infection rates since 2015 and a 12 percent reduction in hepatitis C-related deaths over the same period [1]. Despite these gains, hepatitis B-related deaths have increased by 17 percent since 2015, and viral hepatitis caused approximately 1.3 million deaths in 2024 [1].
Significant obstacles threaten these achievements. Reduced international donor funding in 2025 has disrupted prevention programs in multiple countries, including limiting access to pre-exposure prophylaxis (PrEP) for HIV [1]. The antiviral drug Lenacapavir has been introduced in 10 countries with plans to expand to 14 additional nations [1]. WHO Director-General Tedros Adhanom Ghebreyesus has stressed that "we must build integrated, resilient health systems that serve the people who need them most" [1]. The organization has also released its first integrated guidelines for HIV service delivery and HIV surveillance to strengthen the global response [1].